VcMMAE-Deruxtecan

Overview

VcMMAE -Deruxtecan (VcMMAE-(PAB-GGFG-AMAA)Exatecan; SMP-54418) is a drug-linker conjugate for ADC , composed of linker-payload molecule conjugate VcMMAE ( HY-15575 ) and linker-payload molecule conjugate Deruxtecan (PAB-GGFG-AMAA)Exatecan) ( HY-13631E ). VcMMAE -Deruxtecan can be used in the synthesis of ADCs.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Drug-Linker Conjugates for ADC | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > Topoisomerase

Product Information

• Catalog No.: HY-164835
• CAS No.: 2760408-75-9
• Molecular Formula: C121H159FN20O28
• Molecular Weight: 2360.67
• Purity: 98.01%
• Storage: -20°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source